Bioethics News

Cialis Users Sue Lilly, Claiming Drug Has Ties to Skin Cancer

August 9, 2016

(Indianapolis Business Journal) – Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine. The plaintiffs, from Ohio, Illinois, Texas and other states, filed separate but similar complaints Tuesday in U.S. District Court in Indianapolis, saying that Lilly knew or should have known the drug’s mechanism of action presented “significant risk of exacerbating melanoma.”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.